Corteva, Inc.

Corteva, Inc. (CTVA) Market Cap

Corteva, Inc. has a market capitalization of $54.03B.

Financials based on reported quarter end 2025-12-31

Price: $80.34

β–Ό -0.82 (-1.01%)

Market Cap: 54.03B

NYSE Β· time unavailable

CEO: Charles Victor Magro

Sector: Basic Materials

Industry: Agricultural Inputs

IPO Date: 2019-05-24

Website: https://www.corteva.com

Corteva, Inc. (CTVA) - Company Information

Market Cap: 54.03B Β· Sector: Basic Materials

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

Analyst Sentiment

75%
Strong Buy

Based on 22 ratings

Analyst 1Y Forecast: $82.67

Average target (based on 5 sources)

Consensus Price Target

Low

$82

Median

$87

High

$89

Average

$86

Potential Upside: 7.5%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ Corteva, Inc. (CTVA) β€” Investment Overview

🧩 Business Model Overview

Corteva, Inc. stands as a leading global pure-play agriculture company, with a strategic focus on providing seed and crop protection solutions to the world’s agricultural producers. The company operates through two primary business segments: Seeds and Crop Protection. Corteva develops advanced germplasm, biotechnology traits, digital tools, and crop protection products including herbicides, insecticides, and fungicides. Its principal customers are farmers and commercial agricultural producers globally, with established distribution channels through regional retailers, co-ops, and direct sales teams. Corteva’s footprint covers major agricultural regions, with significant R&D resources driving innovation tailored to local agronomic needs.

πŸ’° Revenue Model & Ecosystem

Corteva’s revenue streams originate from both recurring sales and innovation-driven solutions. Seed sales generally recur annually due to the inherent need for farmers to replenish their inventories, supporting high customer retention. Crop protection revenues arise from both ongoing usage (e.g., herbicides and fungicides applied each growing season) and introduction of patent-protected chemistries or biological products. While primarily focused on B2B relationships with growers and distributors, Corteva increasingly integrates digital agriculture technologies, offering data-driven advisory services and decision-support tools, further embedding itself within the farming lifecycle. This ecosystem approach enables Corteva to capture value across multiple agricultural input categories, leveraging cross-selling opportunities and bundled offerings.

🧠 Competitive Advantages

  • Brand strength: Corteva benefits from a legacy of trusted product brands, many of which originated from its heritage companies, fostering customer loyalty and recognition globally.
  • Switching costs: Farmers face yield risks and agronomic uncertainty when substituting seed or protection products, creating high barriers to supplier change and sustaining Corteva’s customer relationships.
  • Ecosystem stickiness: Integration of digital tools, advisory services, and bundled input solutions deepen engagement, making Corteva a holistic partner rather than a product supplier alone.
  • Scale + supply chain leverage: With global scale and vertically integrated R&D, manufacturing, and distribution, Corteva achieves cost efficiencies and supply chain reliability, supporting broad market access and product innovation.

πŸš€ Growth Drivers Ahead

Several structural catalysts position Corteva for ongoing expansion. Global macro-trends, such as population growth, shifting dietary patterns, and mounting pressure on food systems, amplify demand for improved agricultural productivity. Corteva strategically invests in next-generation seed traits (including climate-resilient genetics), proprietary crop protection formulations, and digital agronomy platforms. Its focus on emerging markets and underpenetrated geographies presents avenues for share gains, while ongoing product pipeline advancements aim to address issues like pest resistance, sustainable farming, and regulatory compliance. Strategic partnerships, sustainability initiatives, and technology licensing further expand the company’s pathways for long-term value creation.

⚠ Risk Factors to Monitor

Corteva operates within a highly competitive and rapidly evolving industry. Intense rivalry from global seed and crop protection peers, as well as generic entrants, places pressure on pricing and innovation cycles. Regulatory shiftsβ€”governing genetically modified organisms, chemical approvals, and environmental requirementsβ€”can disrupt product pipelines and market access. Margin risks stem from fluctuating raw material costs, foreign exchange exposure, and unpredictability in farm incomes. Additionally, technological disruption from emerging biologicals, alternative crop inputs, and digital-only ag solutions presents threats to core business lines if Corteva fails to adapt rapidly.

πŸ“Š Valuation Perspective

The market typically values Corteva in comparison with global agri-science and crop input peers, considering factors such as R&D productivity, product pipeline depth, geographic diversification, and perceived resilience to commodity cycles. As a specialized agriculture company, Corteva’s valuation may command a quality premium for its innovation capabilities, long-term customer contracts, and relatively diversified business model. However, sensitivities to regulatory risk, margin headwinds, or disruptive competition can occasionally result in discounting relative to more broadly diversified chemical or industrial peers.

πŸ” Investment Takeaway

Corteva’s investment thesis rests on its position as a best-in-class agriculture input provider, combining a robust portfolio of patented seeds, crop protection chemistries, and integrated digital solutions. Its global reach, trusted brands, and focus on sustainable farming practices underpin a foundation of competitive advantages. On the bull side, Corteva is well-placed to benefit from secular food demand growth, technological progress in agriculture, and ongoing margin expansion initiatives. Conversely, the company faces notable industry risks, including regulatory uncertainty, evolving competitive dynamics, and margin pressures linked to input costs and price competition. Investors should weigh Corteva’s innovation record, pipeline execution, and ability to adapt to agricultural technological shifts in assessing its long-term return profile.


⚠ AI-generated research summary β€” not financial advice. Validate using official filings & independent analysis.

Corteva delivered a record 2025 with broad-based growth, strong cost execution, and margin expansion above 22%. Management reiterated 2026 guidance for mid-single-digit EBITDA growth and further margin gains, underpinned by productivity, licensing momentum, and CP volume growth in new products and biologicals. The Bayer settlement accelerates key licensing timelines, supports royalty neutrality in 2026, and opens new markets, though near-term headwinds include competitive CP pricing, separation dis-synergies, tariffs, and higher interest expense. Overall tone was confident with a clear path to growth through and beyond the planned 2H 2026 separation.

Growth

  • 2025 organic sales +4% with growth in Seed and Crop Protection
  • 2025 operating EBITDA +14% to $3.85B; margin >22% (+~215 bps)
  • Seed share gains in corn and soy; price/mix +3%, volume +2%
  • Crop Protection volume +5%; biologicals delivered double-digit volume growth
  • 2026 guidance: operating EBITDA $4.0–$4.2B (+~7% YoY midpoint), operating EPS $3.45–$3.70, ~50 bps margin expansion
  • 2026 CP volumes expected up mid-single digits; Seed volumes roughly flat
  • Currency tailwind expected to add ~+$75M to 2026 operating EBITDA

Business Development

  • Reached comprehensive settlement with Bayer; paid $610M
  • Deal accelerates licensing: proprietary triple-stack corn licensing in NA as early as 2027 (accelerated by ~5 years)
  • Accelerates 3rd-gen aboveground trait for NA corn by ~2 years (available by end of decade)
  • Enables entry into U.S. cotton licensing market
  • Expect royalty neutrality in 2026 (2 years early); ~+$1B aggregate earnings upside over 10 years

Financials

  • 2025 operating EBITDA $3.85B; margin >22%
  • 2025 free cash flow $2.9B (+~$1.2B YoY) on higher earnings and working-capital discipline
  • 2025 net royalty expense reduced by ~$90M to ~-$120M
  • 2025 cost improvements >$650M (Seed ~$340M; Crop Protection >$300M)
  • 2025 FX headwind ~$217M on EBITDA
  • 2026 bridge: slight net price up (Seed up; CP down low-single digits); Seed volume flat; CP volume +MSD
  • 2026 productivity savings ~$200M; tariffs headwind ~$80M; FX tailwind ~$75M EBITDA
  • 2026 includes ~$50M net dis-synergies; higher net interest expense expected
  • 2026 seasonality: ~60% of sales and ~85% of EBITDA in 1H

Capital & Funding

  • Returned ~$1.5B to shareholders in 2025 (dividends + buybacks)
  • Declared Q1 dividend; targeting ~$500M of share repurchases in 1H 2026
  • 2026 free cash flow to be impacted by separation items and Bayer payment; absent these, in line with LT targets
  • Engaging credit agencies on capital structures for post-separation companies; commitment to strong balance sheets

Operations & Strategy

  • Separation on track for 2H 2026 (likely Q4): CEO search for new Corteva, SpinCo brand launch, leadership announcements, Form 10 filings, IT separation
  • Investor Days targeted for mid-September
  • Continued 'price for value' strategy in Seed; ongoing asset and sourcing optimization in Crop Protection
  • Advancing out-licensing strategy; full-year impact of Brazil soybean shift to licensing in 2026
  • R&D investment just over 8% of sales; CP pipeline ~$9B of differentiated technologies

Market & Outlook

  • Ag fundamentals mixed: strong food/fuel demand; inventories normal; farmer margins tighter
  • U.S. acreage expected to shift a few million acres from corn to soybeans in 2026 (embedded in guide)
  • Crop Protection market expected to grow modestly in 2026; competitive pricing persists in LATAM and APAC
  • Underlying farmer application demand consistent with historical levels

Risks Or Headwinds

  • Competitive pricing pressure in Latin America and Asia-Pacific (Crop Protection)
  • 2026 tariffs headwind (~$80M)
  • Separation dis-synergies (~$100M total; ~$50M in 2026 guide)
  • FX volatility (2025 headwind; 2026 tailwind assumed)
  • Higher net interest expense in 2026
  • Timing/seasonality of deliveries; weather impacts
  • Farmer margin pressure; CP pricing expected down low single digits

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the CTVA Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"CTVA reported quarterly revenue of $3.91 billion, while net income showed a loss of $552 million, translating to an EPS of -$0.82. Free cash flow was positive at $36 million. Year-over-year growth indicators highlight a period of financial disturbance, possibly transitory. Revenue stability is balanced by current challenges impacting profitability. The company maintains substantial total assets valued at $42.85 billion against total liabilities of $18.46 billion, resulting in a strong equity position and net cash of $1.94 billion. The company's decision to maintain dividend payments of $0.18 per quarter underscores confidence in future prospects. Protein balance sheet stability is evident with active debt management, as reflected by a $739 million debt repayment. Valuation sentiment remains mildly positive with analyst price targets reflecting optimism, although near-term profitability challenges may weigh on sentiment."

Revenue Growth

Fair

Revenue was reported at $3.91 billion, indicating stable topline performance, though the broader implications of the negative earnings need addressing to sustain long-term growth.

Profitability

Neutral

Earnings suffered a setback with a net loss of $552 million and an EPS of -$0.82, suggesting significant profitability challenges.

Cash Flow Quality

Neutral

Free cash flow was $36 million, positively complemented by stable operating cash flows and prudent capital allocation through dividends and buybacks.

Leverage & Balance Sheet

Good

The company's balance sheet is strong, with total equity of $24.39 billion and net cash position, evidencing robust financial resilience.

Shareholder Returns

Positive

Continued commitment to shareholder returns via dividends and share repurchases, despite the earnings downturn, signals strategic confidence.

Analyst Sentiment & Valuation

Positive

Analyst price targets around consensus of $81.5 indicate a moderate level of confidence, though market sentiment might be tested by earnings volatility.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
πŸ“

SEC Filings (CTVA)

Β© 2026 Stock Market Info β€” Corteva, Inc. (CTVA) Financial Profile